Viewing Study NCT05594758


Ignite Creation Date: 2025-12-25 @ 12:14 AM
Ignite Modification Date: 2025-12-25 @ 10:16 PM
Study NCT ID: NCT05594758
Status: AVAILABLE
Last Update Posted: 2024-02-07
First Post: 2022-10-21
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Named Patient Program for Olverembatinib (HQP1351)
Sponsor: Ascentage Pharma Group Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module